Skip to main content

University of Michigan

Intranet
Alumni & friends
Space request
Directory
Giving

Search the Ford School site

Search the Ford School site

Intranet
Alumni & friends
Space request
Directory
Giving

Programs & Courses
Get to know us!

Students, alumni, faculty, and staff perspectives on life at the Ford School, in and out of the classroom.
Learn more
Admissions & Financial Support
Why choose the Ford School?

If you’re eager to lead, to find creative solutions, and to make a big impact on your communities, the Ford School is the right place for you—at the right time.
Learn more
Careers in Public Policy
Explore careers

Alumni spotlights
Research & Impact
Research centers

Cutting-edge. Evidence-based. Collaborative. Engaged.
Learn more
Faculty Expertise
News & Events
Inside the policy-academic ecosystem

How relationships and policy tools help public institutions and Ford School experts co-produce research, test solutions, and scale what works.
Read the spring State & Hill

Home
Ford School News
EpiPen Maker Mylan, Pfizer's Upjohn Off-patent Drug Business To Merge

EpiPen maker Mylan, Pfizer's Upjohn off-patent drug business to merge

August 20, 2019 USA Today

EpiPen maker Mylan, Pfizer's Upjohn off-patent drug business to merge

Marianne Udow-Phillips

Share:

Interdisciplinary expertise, right to your inbox.

Sign up for information about news and events from the Ford School.

Sign up

Event announcements

Gerald R. Ford School of Public Policy
University of Michigan
Joan and Sanford Weill Hall
735 S. State St.
Ann Arbor, MI 48109

About
Alumni & friends
Community resources
Giving
Leadership Initiative

Bluesky Facebook Flickr Instagram LinkedIn Twitter (Classic) YouTube

Contact us
Non-Discrimination Policy
U-M
Webmaster
© The Regents of the University of Michigan